FORM OF CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • August 11th, 2020 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This CONTINGENT VALUE RIGHTS AGREEMENT (this “Agreement”), dated [●], 2020, is by and between Ligand Pharmaceuticals Incorporated, a Delaware limited liability company (“Parent”) and [●], a [●], as rights agent (the “Rights Agent”).
AGREEMENT AND PLAN OF MERGER by and among LIGAND PHARMACEUTICALS INCORPORATED, PELICAN ACQUISITION SUB, INC. and PFENEX INC. Dated as of August 10, 2020Merger Agreement • August 11th, 2020 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated August 10, 2020, is by and among Ligand Pharmaceuticals Incorporated, a Delaware corporation (“Parent”), Pelican Acquisition Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Acquisition Sub”), and Pfenex Inc., a Delaware corporation (the “Company”). Each of Parent, Acquisition Sub and the Company are sometimes referred to as a “Party.” All capitalized terms that are used in this Agreement but not defined in this Agreement shall have the respective meanings ascribed thereto in Annex A.
